Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries United Therapeutic (NQ: UTHR ) 331.44 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 4 Open 331.44 Bid (Size) 313.77 (1) Ask (Size) 344.00 (2) Prev. Close 331.44 Today's Range 331.44 - 331.44 52wk Range 208.62 - 339.56 Shares Outstanding 44,891,523 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Biotech Arvinas Stock Earns 82 RS Rating July 17, 2024 The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82. Via Investor's Business Daily Don't overlook NASDAQ:UTHR—it's a hidden gem with strong fundamentals and an attractive price tag. July 17, 2024 Despite its impressive fundamentals, UNITED THERAPEUTICS CORP (NASDAQ:UTHR) remains undervalued. Via Chartmill Performance YTD +45.78% +45.78% 1 Month +11.57% +11.57% 3 Month +40.85% +40.85% 6 Month +49.13% +49.13% 1 Year +39.31% +39.31% More News Read More Denali Therapeutics Stock Gets Technical Rating Upgrade July 16, 2024 Via Investor's Business Daily If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today July 16, 2024 Via Benzinga 3 Biotech Stocks to Buy Now: Q3 Edition July 15, 2024 Via InvestorPlace United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis July 10, 2024 From United Therapeutics Corporation Via Business Wire Unveiling 6 Analyst Insights On United Therapeutics July 08, 2024 Via Benzinga Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings) June 12, 2024 Via Benzinga 3 Undervalued Stocks on Track to Double (or More) by 2028 July 08, 2024 Via InvestorPlace Members of Congress Buy and Sell Stocks. These ETFs Let You Invest Like Democrats or Republicans. July 02, 2024 Via The Motley Fool Topics ETFs 7 Undervalued Biotech Stocks to Buy for Big-Time Returns July 01, 2024 Via InvestorPlace Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses June 28, 2024 Via Talk Markets UroGen Pharma Stock Earns 91 RS Rating June 27, 2024 Via Investor's Business Daily United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors June 27, 2024 From United Therapeutics Corporation Via Business Wire When you look at NASDAQ:UTHR, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. June 26, 2024 Via Chartmill Arcellx Stock Earns Relative Strength Rating Upgrade June 21, 2024 Via Investor's Business Daily The 3 Best Medical Device Stocks to Buy in June 2024 June 20, 2024 Via InvestorPlace Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87 June 20, 2024 Via Investor's Business Daily 10 Health Care Stocks Whale Activity In Today's Session June 19, 2024 Via Benzinga Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans June 14, 2024 Via Investor's Business Daily Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade June 12, 2024 Via Investor's Business Daily Krystal Biotech Stock Sees RS Rating Jump To 91 June 11, 2024 Via Investor's Business Daily 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga Halozyme Therapeutics Scores RS Rating Jump To 91 June 07, 2024 Via Investor's Business Daily For those who appreciate value investing, NASDAQ:UTHR is a compelling option with its solid fundamentals. June 05, 2024 Via Chartmill Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
